Generation of a permanent cell line that supports efficient growth of Marek′s disease virus (MDV) by constitutive expression of MDV glycoprotein E

References

1. Abujoub A., Coussens P. M. 1995; Development of a sustainable chick cell line infected with Marek′s disease virus. Virology 214:541–549
   [Google Scholar]
2. Abujoub A. A., Coussens P. M. 1997; Evidence that Marek′s disease virus exists in a latent state in a sustainable fibroblast cell line. Virology 229:309–321
   [Google Scholar]
3. Benton W. J., Cover M. S. 1957; The increased incidence of visceral lymphomatosis in broiler and replacement birds. Avian Disease320–327
   [Google Scholar]
4. Biggs P. M. 2001; The history and biology of Marek’s Disease Virus. In Marek’s Disease pp 1–25 Edited by Kanji H. Berlin, Heidelberg & New York: Springer-Verlag;
   [Google Scholar]
5. Brunovskis P., Velicer L. F. 1995; The Marek′s disease virus (MDV) unique short region: alphaherpesvirus-homologous, fowlpox virus-homologous, and MDV-specific genes. Virology 206:324–338
   [Google Scholar]
6. Calnek B. W. 2001; Pathogenesis of Marek′s disease virus infection. In Marek’s Disease pp 25–55 Edited by Kanji H. Berlin, Heidelberg & New York: Springer-Verlag;
   [Google Scholar]
7. Calnek B. W., Schat K. A., Peckham M. C., Fabricant J. 1983; Field trials with a bivalent vaccine (HVT and SB-1) against Marek′s disease. Avian Disease 27:844–849
   [Google Scholar]
8. Dorange F., Tischer B. K., Vautherot J. F., Osterrieder N. 2002; Characterization of Marek′s disease virus serotype 1 (MDV-1) deletion mutants that lack UL46 to UL49 genes: MDV-1 UL49, encoding VP22, is indispensable for virus growth. Journal of Virology 76:1959–1970
   [Google Scholar]
9. Jaikumar D., Read K. M., Tannock G. A. 2001; Adaptation of Marek′s disease virus to the Vero continuous cell line. Veterinary Microbiology 79:75–82
   [Google Scholar]
10. Lee L. F., Wu P., Sui D., Ren D., Kamil J., Kung H. J., Witter R. L. 2000; The complete unique long sequence and the overall genomic organization of the GA strain of Marek′s disease virus. Proceedings of the National Academy of Sciences, USA 97:6091–6096
    [Google Scholar]
11. Mettenleiter T. C. 2002; Herpesvirus assembly and egress. Journal of Virology 76:1537–1547
    [Google Scholar]
12. Morgan R. W., Cantello J. L., McDermott C. H. 1990; Transfection of chicken embryo fibroblasts with Marek′s disease virus DNA. Avian Disease 34:345–351
    [Google Scholar]
13. Osterrieder N., Wagner R., Brandmüller C., Schmidt P., Wolf H., Kaaden O. R. 1995; Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB). Virology 208:500–510
    [Google Scholar]
14. Rispens B. H., van Vloten H., Mastenbroek N., Maas H. J., Schat K. A. 1972a; Control of Marek′s disease in the Netherlands. I. Isolation of an avirulent Marek′s disease virus (strain CVI 988) and its use in laboratory vaccination trials. Avian Disease 16:108–125
    [Google Scholar]
15. Rispens B. H., van Vloten H., Mastenbroek N., Maas J. L., Schat K. A. 1972b; Control of Marek′s disease in the Netherlands. II. Field trials on vaccination with an avirulent strain (CVI 988) of Marek′s disease virus. Avian Disease 16:126–138
    [Google Scholar]
16. Saiki R. K., Bugawan T. L., Horn G. T., Mullis K. B., Erlich H. A. 1986; Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature 324:163–166
    [Google Scholar]
17. Schat K. A., Calnek B. W., Fabricant J. 1982; Characterisation of two highly oncogenic strains of Marek′s disease virus. Avian Pathology 593–605
    [Google Scholar]
18. Schumacher D., Tischer B. K., Fuchs W., Osterrieder N. 2000; Reconstitution of Marek′s disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant. Journal of Virology 74:11088–11098
    [Google Scholar]
19. Schumacher D., Tischer B. K., Reddy S. M., Osterrieder N. 2001; Glycoproteins E and I of Marek′s disease virus serotype 1 are essential for virus growth in cultured cells. Journal of Virology 75:11307–11318
    [Google Scholar]
20. Tischer B. K., Schumacher D., Messerle M., Wagner M., Osterrieder N. 2002; The products of the UL10 (gM) and the UL49.5 genes of Marek′s Disease Virus serotype 1 (MDV-1) are essential for virus growth in cultured cells. Journal of General Virology 83:997–1003
    [Google Scholar]
21. Tulman E. R., Afonso C. L., Lu Z., Zsak L., Rock D. L., Kutish G. F. 2000; The genome of a very virulent Marek′s disease virus. Journal of Virology 74:7980–7988
    [Google Scholar]
22. Witter R. L. 1983; Characteristics of Marek′s disease viruses isolated from vaccinated commercial chicken flocks: association of viral pathotype with lymphoma frequency. Avian Disease 27:113–132
    [Google Scholar]
23. Witter R. L. 1992 Safety and comparative efficacy of the CVI988/Rispens vaccine strain World′s Poultry Science Association; Amsterdam:315–319
    [Google Scholar]
24. Witter R. L. 1997; Increased virulence of Marek′s disease virus field isolates. Avian Disease 41:149–163
    [Google Scholar]
25. Witter R. L. 2001; Protective efficacy of Marek′s disease vaccines. In Marek′s Disease pp 57–90 Edited by Hirai K. Berlin, Heidelberg & New York: Springer-Verlag;
    [Google Scholar]
26. Witter R. L., Lee L. F., Fadly A. M. 1995; Characteristics of CVI988/Rispens and R2/23, two prototype vaccine strains of serotype 1 Marek′s disease virus. Avian Disease 39:269–284
    [Google Scholar]